ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department
The Journal of Applied Laboratory Medicine · 05.01.2026 · 11 (1) · 155-180
DOI: 10.1093/jalm/jfaf172 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 05.01.2026. Verfasst von Christine L H Snozek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, AZ, United States. Hauptthemen laut MEDLINE: Substance Abuse Detection, Emergency Service, Hospital, Substance-Related Disorders, Illicit Drugs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Toxicology testing for drugs associated with scenarios such as recreational use or substance use disorder can be performed in support of the emergency department (ED) for specific patient populations such as pediatrics and trauma. These compounds were historically referred to as drugs of abuse (DOA); although the word “abuse” is recognized as potentially stigmatizing, no replacement terminology for DOA has emerged in current guidelines. This document refers to these compounds as drugs or substances of misuse, and acknowledges the need for less-stigmatizing language that more fully encompasses the range of uses for these drugs. This literature-driven, consensus guidance document provides recommendations primarily targeted to US hospital-based laboratories performing urine drug testing (UDT) in support of the ED. Indications for ordering UDT and related testing in both pediatric and adult populations are summarized. Further, recommendations are made for testing that should be available at all facilities with rapid turnaround, and how to perform and report testing. The advantages and disadvantages of immunoassays and mass spectrometry, as well as common challenges, are reviewed. Indications for mass-spectrometry assays and more extensive testing (e.g., novel psychoactive substances) are also provided. Future directions for improvements in laboratory technology to improve the utility of this testing are outlined. All laboratories should collaborate with ED leadership, medical toxicologists and poison control centers to optimize and update test menus to reflect local drug use patterns, ensure test methodologies and results meet clinical needs, and educate clinical staff regarding assay limitations and accurate test interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, AZ, United States.
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, United States.
- Premier Biotech Labs LLC, Minneapolis, MN, United States.
- Department of Pathology, University of Utah Health, Salt Lake City, UT, United States.
- ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
- Departments of Medicine and Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, United States.
ORCID-Profile: Christine L H Snozek, Matthew D Krasowski
Zitieren
APA
Snozek, C. L. H., Krasowski, M. D., Colby, J. M., Johnson-Davis, K. L., Bruccoleri, R. E., & Melanson, S. E. (2026). ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department. The Journal of Applied Laboratory Medicine, 11(1), 155-180. https://doi.org/10.1093/jalm/jfaf172
Vancouver
Snozek CLH, Krasowski MD, Colby JM, Johnson-Davis KL, Bruccoleri RE, Melanson SE. ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department. The Journal of Applied Laboratory Medicine. 2026;11(1):155-180. doi:10.1093/jalm/jfaf172
BibTeX
@article{Snozek2026,
author = {Snozek, Christine L H and Krasowski, Matthew D and Colby, Jennifer M and Johnson-Davis, Kamisha L and Bruccoleri, Rebecca E and Melanson, Stacy E},
title = {ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {1},
pages = {155--180},
doi = {10.1093/jalm/jfaf172}
}
EUVIMED